Rockwell Medical (NASDAQ:RMTI) Cut to Hold at StockNews.com

StockNews.com lowered shares of Rockwell Medical (NASDAQ:RMTI) from a buy rating to a hold rating in a research note issued to investors on Thursday morning.

A number of other brokerages have also recently issued reports on RMTI. HC Wainwright reissued a “buy” rating and set a $9.00 target price on shares of Rockwell Medical in a report on Wednesday, September 11th. Rodman & Renshaw started coverage on shares of Rockwell Medical in a report on Thursday, November 14th. They issued a “buy” rating and a $5.00 price target on the stock. Finally, RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th.

Rockwell Medical Trading Up 2.3 %

Shares of RMTI stock opened at $2.25 on Thursday. The company’s fifty day simple moving average is $3.53 and its two-hundred day simple moving average is $2.64. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $5.15. The stock has a market capitalization of $72.72 million, a price-to-earnings ratio of -45.00 and a beta of 1.50.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Armistice Capital LLC grew its position in Rockwell Medical by 22.5% in the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after acquiring an additional 592,000 shares in the last quarter. Vanguard Group Inc. grew its position in Rockwell Medical by 4.0% in the first quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock worth $1,856,000 after acquiring an additional 43,302 shares in the last quarter. Jane Street Group LLC purchased a new position in Rockwell Medical in the third quarter worth $534,000. Walleye Capital LLC purchased a new position in Rockwell Medical in the third quarter worth $435,000. Finally, Renaissance Technologies LLC grew its position in Rockwell Medical by 877.1% in the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after acquiring an additional 92,189 shares in the last quarter. Institutional investors own 23.31% of the company’s stock.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.